The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Perspective Therapeutics (CATX – Research Report) today and set a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback